Chris Teo

Chris Teo has a robust background in the pharmaceutical industry, with expertise spanning over a decade and a half. Currently employed as a Scientist II at Aurobindo Pharma USA, Inc. since October 2022, Chris previously held positions at Catalent Pharma Solutions as a Scientist from September 2010 to May 2023, and at Oriel Therapeutics as a Research Associate from June 2009 to June 2010. Earlier career experience includes serving as an Associate Scientist at GlaxoSmithKline from 2003 to 2009.